# A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine

> **NCT01764256** · PHASE1 · COMPLETED · sponsor: **PATH** · enrollment: 48 (actual)

## Conditions studied

- Rotavirus Infection

## Interventions

- **BIOLOGICAL:** P2-VP8 subunit rotavirus vaccine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01764256
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764256, "A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01764256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*